Your browser doesn't support javascript.
loading
Clinical development and review times for new drugs in Japan: associated factors.
Ishibashi, T; Yasuda, K; Kusama, M; Sugiyama, Y; Ono, S.
Affiliation
  • Ishibashi T; Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan. ishibashi@mol.f.u-tokyo.ac.jp
Clin Pharmacol Ther ; 88(4): 487-91, 2010 Oct.
Article in En | MEDLINE | ID: mdl-20739921
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Clinical Trials as Topic / Drug Approval / Drug Industry Type of study: Diagnostic_studies / Risk_factors_studies Limits: Humans Country/Region as subject: Asia Language: En Journal: Clin Pharmacol Ther Year: 2010 Document type: Article Affiliation country: Japan Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Clinical Trials as Topic / Drug Approval / Drug Industry Type of study: Diagnostic_studies / Risk_factors_studies Limits: Humans Country/Region as subject: Asia Language: En Journal: Clin Pharmacol Ther Year: 2010 Document type: Article Affiliation country: Japan Country of publication: United States